More Articles Back to Article
- Aligning Stakeholder Partnerships in Latin America
- Policies to Promote Development of AI-Based Medical Devices in Japan
- Conversation with Australian Pharmaceutical medical and scientific Professionals Association (APPA) Past President David Grolman
- Patient Entrepreneurs: The New Driving Force for Developing Health Solutions
- Perspectives on FDA’s Accelerated Approval Program
Policies to Promote Development of AI-Based Medical Devices in Japan
The number of AI-based medical devices approved in Japan is still low compared to Europe and the US, but Japan has become one of the countries with the most advanced policies on artificial intelligence-based medical devices.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!